These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9306398)

  • 1. Europe's enthusiasm for entrepreneurism.
    Lähteenmäki R; Plant D; Michael A
    Nat Biotechnol; 1997 Sep; 15(9):852-3. PubMed ID: 9306398
    [No Abstract]   [Full Text] [Related]  

  • 2. Will industry play a bigger role in Europe's aims to promote mobility among postdocs?
    Hinck S; Schiermeier Q
    Nature; 2003 Jan; 421(6920):296-7. PubMed ID: 12529652
    [No Abstract]   [Full Text] [Related]  

  • 3. Could bank loans solve Europe's biotech financing slump?
    Mitchell P
    Nat Biotechnol; 2005 Dec; 23(12):1459-60. PubMed ID: 16333276
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotechnology in the Bay.
    Niiler E
    Nat Biotechnol; 2000 Mar; 18(3):280-1. PubMed ID: 10700141
    [No Abstract]   [Full Text] [Related]  

  • 5. Changing talent needs to realize biotech products.
    Rafferty MA
    Nat Biotechnol; 2004 Oct; 22(10):1327. PubMed ID: 15470474
    [No Abstract]   [Full Text] [Related]  

  • 6. Europe's biotech industry still losing to US, say analysts.
    Schiermeier Q
    Nature; 2001 May; 411(6836):404. PubMed ID: 11373636
    [No Abstract]   [Full Text] [Related]  

  • 7. Life science careers: how to make best use of Europe's brains.
    Epstein I
    N Biotechnol; 2009 Sep; 25(6):389. PubMed ID: 19591964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotechnology SMEs, start-ups, spin-offs or microenterprises are they molecules coming from the research results? If so, what place do they hold in the global industrial tissue?
    Doddoli R
    Biomol Eng; 2007 Feb; 24(1):3-4. PubMed ID: 16887388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nurturing the business of biotechnology.
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE1. PubMed ID: 12089568
    [No Abstract]   [Full Text] [Related]  

  • 10. Europe discovers bioentrepreneurship.
    Haycock P
    Nat Biotechnol; 1998 May; 16 Suppl():6. PubMed ID: 9591249
    [No Abstract]   [Full Text] [Related]  

  • 11. Growing an international biotechnology company.
    Brandys P
    Nat Biotechnol; 1998 May; 16 Suppl():5. PubMed ID: 9591248
    [No Abstract]   [Full Text] [Related]  

  • 12. The rise of European venture capital for biotechnology.
    Howell M; Trull M; Dibner MD
    Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotech jobs are still around despite the recent bumpy ride.
    Smaglik P; Smith A
    Nature; 2002 Jul; 418(6893):4-5. PubMed ID: 12097871
    [No Abstract]   [Full Text] [Related]  

  • 14. The startup balancing act: hiring the right talent.
    Moroney S
    Nat Biotechnol; 1998 May; 16 Suppl():39-40. PubMed ID: 9591265
    [No Abstract]   [Full Text] [Related]  

  • 15. The rise of the European bioentrepreneur.
    Alper J
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE3-5. PubMed ID: 12089569
    [No Abstract]   [Full Text] [Related]  

  • 16. Shutters come off IPO window.
    Hodgson J
    Nat Biotechnol; 2002 Jan; 20(1):6. PubMed ID: 11753342
    [No Abstract]   [Full Text] [Related]  

  • 17. Taiwan: Biotech vision.
    Cyranoski D
    Nat Biotechnol; 2003 Apr; 21(4):463-4. PubMed ID: 12665831
    [No Abstract]   [Full Text] [Related]  

  • 18. Alternative approaches.
    Smaglik P
    Nature; 2003 Jan; 421(6921):455. PubMed ID: 12540922
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotech's balancing act.
    Smaglik P
    Nature; 2003 May; 423(6937):363. PubMed ID: 12748656
    [No Abstract]   [Full Text] [Related]  

  • 20. Making it in the biotech business.
    Gewin V
    Nature; 2005 May; 435(7038):124-5. PubMed ID: 15875029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.